A Study of the Psycho-social Effects of Next Generation Sequencing Panels for Predictive Testing of Hereditary Neurodegenerative Disease
Predictive testing for neurodegenerative diseases
Sponsor: Taub Institute
Enrolling: Male and Female Patients
Study Length: 1 Days
Clinic Visits: 2
IRB Number: AAAQ2325
Contact: Jill Goldman MS MPhil CGC: 212-305-7382 / jg2673@cumc.columbia.edu
Additional Study Information: This study is recruiting people who have a family history of a neurodegenerative diseases, such as Alzheimer's disease or other form of dementia including frontotemporal dementia and prion disease, who are interested in doing predictive genetic testing. Participants will complete questionnaires prior to testing and then 1 month and 6 months after results have been given. A brief interview will also occur at 6 months. Participants will meet with a genetic counselor and a neurologist prior to testing to discuss the symptoms and genetics of the disease in the family.
This study is closed
Investigator
Karen Marder, MD, MPH
Do You Qualify?
Do you speak English? Yes No
Do you have a first degree family member with a degenerative disease such as Alzheimer's with onset before 65? Yes No
Do you have at least 1 other person in the family with a similar disease? Yes No
Are you between 21 and 75 years of age? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Jill Goldman MS MPhil CGC
jg2673@cumc.columbia.edu
212-305-7382
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE